Home
About
Overview
Sharing Data
ORCID
Help
History (33)
Phase I dose-escalation studies of SNX-5422, an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumours.
Deletion of 16q24.1 supports a role for the ATP2C2 gene in specific language impairment.
The effects of aqueous and ethanolic extracts of Rheum ribes on insulin-resistance and apolipoproteins in patients with type 2 diabetes mellitus: a randomized controlled trial.
Trichomonas
Reviewing concomitant medications for participants in oncology clinical trials.
See All 33 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Reviewing concomitant medications for participants in oncology clinical trials.
McGahey KE, Weiss GJ. Reviewing concomitant medications for participants in oncology clinical trials. Am J Health Syst Pharm. 2017 Apr 15; 74(8):580-586.
View in:
PubMed
subject areas
Adult
Antineoplastic Agents
Clinical Trials as Topic
Drug Interactions
Drugs, Investigational
Humans
Neoplasms
Practice Guidelines as Topic
authors with profiles
Glen Weiss MD, MBA